INTRODUCTION
Alterations in the type and quantity of serum immunoglobulins in rheumatic diseases have been well appreciated (1) (2) (3) (4) (5) (6) . The participation of these globulins in the formation of immune complexes has given them a posReceived for publication 28 July 1969. sible pathogenetic role in diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) (1, 2) . Gammaglobulin serum concentrations appear to have little diagnostic or prognostic significance in any single patient and do not differ significantly in these two diseases. Studies in patients with SLE (3) and RA (4) (5) (6) suggest that there is a significant mean increase of serum IgG levels in both these disorders. Elevations in serum IgG levels, however, are not uniform and many values fall within the normal range. Elevation of serum IgM levels even in patients with high titers of rheumatoid factor were found to be inconstant (5) .
Serum immunoglobulin concentration is a static determination and gives only a partial understanding of the dynamic nature of these proteins. Turnover studies, utilizing radioiodinated globulins, measure their catabolism and indirectly their synthesis and thus more closely reflect the activity of these proteins in disease.
IgG catabolism has been found to be markedly prolonged in congenital and acquired hypogammaglobulinemia (7) and accelerated in myotonic dystrophy (8) and in hypergammaglobulinemic states such as hyperimmunization, chronic infection, and multiple myeloma (9) (10) (11) and 'I were removed by passage through an anion exchange column (Bio-Rad AG 1-x4) so that greater than 97% of the product's radioactivity was precipitable. 70 mg of sterile human albumin was added per ml to prevent damage due to self radiation and the preparation was sterilized by passage through a 0.22 0 Millipore filter.
After radioiodine labeling lack of denaturation of the labeled protein was demonstrated by adding trace amounts of "lI-labeled IgG to an excess of fresh normal serum and chromatographing the mixture on DEAE-cellulose with a constant phosphate gradient (22) . Radioiodine elution was identical with and limited to the first effluent peak representing native IgG.
Study protocol. Patients received 10 drops of Lugol's solution twice daily for 3 days before and during the entire study period to prevent thyroidal uptake of released radioiodine. Approximately 10 ACi of each labeled immunoglobulin was injected intravenously and the biological half-lives were calculated over a 21 day period by 8-10 serial determinations of radioactivity in the blood and urine in a gamma well counter, Nuclear Chicago, model No. 42-33 and by serial counts of total body radioactivity for 'I by use of a total body counting chamber.
The total body counter consists of four uncollimated NaI scintillation detectors each 5 X 4 inches in diameter, arranged in pairs above and below a cot upon which the subject rests in the supine position. The cot is placed in the center of a room having walls, ceiling, floor, and doors all of 6 inch steel with a * inch thick inner lining of lead.
Plasma volumes were calculated by evaluation of 10-min IgM-wI samples. Patients with proteinuria were studied with quantitative immunoglobulin determinations on their urine and those patients found to have significant amounts of IgG or IgM had urine analyzed for protein-bound radioactivity. In no patients was significant urinary protein-bound radioactivity found.
Serial immunoglobulin concentrations were determined using the radial immunodiffusion assay (19) to establish the steady state in all our patients. Rheumatoid factor was evaluated and titers quantitated by tube dilution techniques using both latex particles coated with human gammaglobulin (17) and sensitized sheep cells coated with rabbit gammaglobulin (18) . All patients were studied for antinuclear antibodies by the method of immunofluorescent staining of human leukocytes (20) .
Analysis of data. IgG serum and total body radioactivity were plotted on semilogarithmic paper against time and their biological half-lives were determined graphically.
Fractional catabolic rate defined as the fraction of total body IgG catabolized per day was derived from the equation for exponential decay. Fractional catabolic rate (%) = Ln2/tj (half-life) = 0.693/ti.
Absolute synthetic rate was defined as the daily quantity of IgG catabolized, expressed as milligrams per kilogram per day. In the steady state, this rate also describes the daily quantity of IgG synthesized. Absolute synthetic rate was derived from the total body fractional catabolic rate according to the method of Berson, Yalow, Schreiber, and Post (23) , and the method of Sterling (24) . Absolute synthetic rate (mg/kg/day) = total body globulin pool (mg) X fractional catabolic rate (o/day) /body weight (kg). Total body globulin pool (g) = plasma volume X serum immunoglobulin concentration X 100/per cent of total body globulin pool that is intravascular. Plasma volume (ml) = radioactivity administered/activity per ml of plasma at zero time (10-min samples). Per cent of body pool intravascular was computed by the graphic extrapolation method of Sterling, per cent intravascular = 100 X extrapolation to zero time of the linear portion of the plasma radioactivity curve/activity administered, and by modification of the method of Berson et al., utilizing total body radioactivity, both by direct measurement of total body counts and by subtraction of cumulative urinary radioiodine excretion. Per cent intravascular = 100 X the total plasma radioactivity/radioactivity retained in body. Calculations by both these methods yielded comparable results.
IgG absolute synthetic rate was also calculated according to the U/P method, of Pearson, Veall, and Vetter (25) by deriving the fraction of intravascular IgG catabolized per day. Absolute synthetic rate (mg/kg/day) = fraction intravascular globulin pool catabolized per day X total intravascular pool/body weight. Fraction of the intravascular globulin pool catabolized per day = radioactivity lost daily (urine or total body counts)/mean intravascular radioactivity during that day. Total intravascular globulin pool = plasma volume X serum immunoglobulin concentration. Synthetic rates calculated by this method yielded values within 10% of the previous method.
IgM turnover data was calculated by analysis of serum curves alone. This is due to the low energy level of 'I making it unsuitable for total body counting. Objections to Sterling's method of calculation based on theoretical differences of protein activity in different body compartments are minimized in the case of IgM because of the primary intravascular site of this protein. Synthetic rates calculated by this method were confirmed by the U/P method in six patients.
RESULTS
Our data in 20 patients with SLE and RA and in 7 normal controls are summarized for IgG metabolism in Table I and for IgM metabolism in Table II . Normal controls. In seven normal volunteers metabolic studies of our IgG preparation revealed a halflife ranging from 13 to 25 days with a mean half-life of 18.0 days, a fractional catabolic rate ranging from 2 to 5%/day with a mean of 3.9%/day and an absolute synthetic rate ranging from 15 to 50 mg/kg per day with a mean of 35 mg/kg per day. Mean serum IgG concentration was 1070 mg/100 ml. Metabolic studies of our IgM preparation in normals showed it to have a half-life ranging from 6 to 13 days with a mean of 9.3 days, a fractional catabolic rate ranging from 5 to 12%! day with a mean of 8.1 %/day, and an absolute synthetic rate ranging from 2 to 10 mg/kg per day with a mean of 6.0 mg/kg per day. Mean IgM serum concentration was 95 mg/100 ml.
Systemic lupus erythematosus. Studies in 10 patients
with SLE revealed a marked acceleration in turnover of IgG as compared to normals, with a mean half-life of 8.2 ±1.1 days (P < 0.001), a mean catabolic rate of 10.1 ±1.6%/day (P < 0.01), and a mean synthetic rate of 127.5 ±41.6 mg/kg per day (P < 0.05). Turnover of IgM, however, was with few exceptions, normal. IgG serum concentration was elevated in five patients With appropriate preparation of materials it has been well established that radioiodinated globulins are metabolized in the same manner as their native proteins and are suitable for turnover studies (27, 28 (8) and the immune clearance of IgA found in some patients with ataxia telangiectasia (29) . The determinants of IgG catabolism in SLE are probably multiple and may involve both known as well as yet undefined mechanisms.
Animal studies (30) (31) (32) (7, 11, 33) . Conditions marked by an increase in IgG serum concentration such as cirrhosis of the liver, chronic infections, and multiple myeloma have been associated with an increased catabolic rate (34, 35) .
Other factors which may contribute to a primary IgG hypercatabolism may involve changes at the site of IgG catabolism. Work by Truax and McCoy (36) in the rat strongly suggests that the kidney is the major site of IgG catabolism. In the mouse, the kidney has been shown to be the primary site for the catabolism of some immunoglobulin fragments (37) . The (43) and cold agglutinin disease may not be relevant to studies in RA. Broad band polyclonal serum IgM elevations, as high as 500 mg/100 ml, as seen in our patients with RA, may have an effect on catabolic rate which differs from the effect of a narrow band homogeneous IgM elevation. The variability of the catabolic response to paraproteins has been well demonstrataed in the case of IgG paraproteins in multiple myeloma where only some IgG paraproteins appear able to increase the catabolic rate (11) . A similar mechanism may explain the failure of increased macroglobulin paraprotein in some patients with macroglobulinemia to influence their IgM catabolic rates.
Patients with RA in our study had a twice normal mean IgM serum concentration. Although no direct correlation between the degree of hypercatabolism and serum IgM concentration is evident (Fig. 1) , the two patients with RA who demonstrated normal serum IgM concentration exhibited normal turnover. The remaining eight patients showed increased IgM catabolism and generally an elevated IgM serum concentration. An apparent influence of IgM serum concentration on IgM catabolism is suggested by the positive correlation (P < 0.05) between serum concentration and fractional catabolic rate in 10 patients with SLE (Fig. 2 ).
An additional primary mechanism which may be acting to increase IgM catabolism in RA may be related to increased blood clearance secondary to anti-IgM globulins if present, or to an enhanced ability in RA for removal of aggregated or precipitated proteins from the circulation, first postulated by Vaughan et al. (12) . Increased reticuloendothelial clearance which has been described in RA (51) could preferentially clear denatured or complexed IgM before phagocytosis of smaller proteins such as IgG. Further work to investigate these hypotheses is presently being pursued in this laboratory.
